Richard Burke Biography and Net Worth

Director of Clearside Biomedical

Richard Taylor Burke, Sr. is Lead Independent Director of the Company, since September 1, 2017. Mr. Burke is Lead Independent Director of the Board of Directors of UnitedHealth Group and has served in that capacity since September 2017. Mr. Burke served as Chairman of the Board from 2006 to August 2017, has been a member of our Board since 1977, and was Chief Executive Officer of UnitedHealthcare, Inc., our predecessor corporation, until 1988. From 1995 until 2001, Mr. Burke was the owner, Chief Executive Officer and Governor of the Phoenix Coyotes, a National Hockey League team. Mr. Burke currently serves as a director of Meritage Homes Corporation.

What is Richard T. Burke's net worth?: The estimated net worth of Richard T. Burke is at least $1.13 million as of May 19th, 2022. Mr. Burke owns 1,215,000 shares of Clearside Biomedical stock worth more than $1,129,950 as of April 3rd. This net worth estimate does not reflect any other investments that Mr. Burke may own. Learn More about Richard T. Burke's net worth.
How do I contact Richard T. Burke?: The corporate mailing address for Mr. Burke and other Clearside Biomedical executives is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005. Clearside Biomedical can also be reached via phone at (678) 270-3631 and via email at charlie.deignan@clearsidebio.com. Learn More on Richard T. Burke's contact information.
Has Richard T. Burke been buying or selling shares of Clearside Biomedical?: Richard T. Burke has not been actively trading shares of Clearside Biomedical within the last three months. Learn More on Richard T. Burke's trading history.
Who are Clearside Biomedical's active insiders?: Clearside Biomedical's insider roster includes Richard Burke (Director), Thomas Ciulla (Insider), Charles Deignan (CFO), George Lasezkay (CEO), and Bradford Whitmore (Major Shareholder). Learn More on Clearside Biomedical's active insiders.
Are insiders buying or selling shares of Clearside Biomedical?: In the last year, Clearside Biomedical insiders bought shares 5 times. They purchased a total of 89,523 shares worth more than $93,832.53. The most recent insider tranaction occured on February, 24th when Director Clay Thorp bought 15,000 shares worth more than $13,800.00. Insiders at Clearside Biomedical own 9.2% of the company. Learn More about insider trades at Clearside Biomedical.
Information on this page was last updated on 2/24/2025.

Richard T. Burke Insider Trading History at Clearside Biomedical

Richard T. Burke Buying and Selling Activity at Clearside Biomedical

Clearside Biomedical Company Overview

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Today's Range

Now: $0.93

$0.90

$0.94

50 Day Range

MA: $0.96

$0.79

$1.13

2 Week Range

Now: $0.93

$0.77

$1.65

Volume

62,021 shs

Average Volume

351,562 shs

Market Capitalization

$71.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03